期刊文献+

妊娠合并甲状腺功能亢进60例临床分析 被引量:4

Clinical Analysis of 60 Pregnant Women with Hyperthyroidism
下载PDF
导出
摘要 目的探讨妊娠合并甲亢的诊断、治疗和妊娠结局。方法回顾性分析我院2003年1月~2008年12月收治的妊娠合并甲亢60例患者的资料,按孕期是否正规治疗分为对照组和治疗组,对照组22例,治疗组各38例。结果①甲状腺激素水平:对照组FT3、FT4水平明显高于治疗组,TSH明显降低(P<0.01)。②妊娠结局:对照组引产、早产、流产、小于胎龄儿、死胎发生率高于治疗组(P<0.05)。③妊娠并发症:对照组妊娠糖尿病、妊娠高血压疾病、甲亢性心脏病高于治疗组(P<0.05)。结论妊娠合并甲状腺功能亢进症早期诊断、规范治疗,并定期监测可有效减少母儿并发症的发生,改善妊娠结局。 Objective To study the diagnosis, treatment and pregnant outcome of hyperthyroidism during pregnancy. Methods A retrospective analysis was conducted for hyperthyroidism during pregnancy admitted to our hospital from January 2003 to December 2008.60 cases were divided two groups, treatment group (n=38) and control group (n=22), according to whether the standardized treatment used or not. Results ① The level of thyroid hormones: The level of FT3, FT4 was great higher in control group than treatment group (P 〈0.01);The level of TSH was much lower in control group than treatment group (P〈0.01). ②Pregnant outcome: The incidence of induced labor, premature, abortion, small for gestational age infants and fetal death was higher in control group than treatment group (P 〈0.05); ③Pregnant complications: Gestational diabetes, gestational hypertension disease, heart disease from hyperthyroidism were much higher in the control group than those in the treatment group (P〈0.05). Conclusion Early diagnosis, treatment and regular monitoring of pregnant women with hyperthyroidism may effectively reduce maternal and fetal complications and improve the pregnant outcome.
出处 《临床医学工程》 2009年第9期38-39,共2页 Clinical Medicine & Engineering
关键词 妊娠 甲状腺功能亢进症 妊娠并发症 妊娠结局 Pregnancy hyperthyroidism pregnant complications pregnant outcome
  • 相关文献

参考文献1

二级参考文献10

  • 1Cooper DS. Hyperthyroidism. Lancet, 2003,362 : 459-468.
  • 2American College of Obstetrics and Gynecology. ACOG practice bulletin. Thyroid disease in pregnancy. Number 37, August 2002.American College of Obstetrics and Gynecology. Int J Gynaecol Obstet ,2002,79 : 171-180.
  • 3Omotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol, 1984,20 :695-700.
  • 4Wing DA, Millar LK, Koonings PP, et al. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol, 1994,170:90-95.
  • 5Clementi M, Di Gianantonio E, Pelo E, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet, 1999,83:43-46.
  • 6Martinez-Frias ML, Cereijo A, Rodriguez-Pinilla E, et al.Methimazole in the animal feed and congenital aplasis cutis. Lancet,1992, 339:742-743.
  • 7Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab, 2001,86:2354-2359.
  • 8Diez-Delgado R j, Belmonte- Martin M J, Calvo-Bonachera MD, et al. Aplasia cutis as a teratogentic effect of methimazole. An Esp Pediatr, 1999,51 : 290-292.
  • 9Wilson LC, Kerr BA, Wilkinson R, et al. Choanal atresia and hypothelia following methimazole exposure in utero: a second report. Am J Med Genet, 1998,75:220-222.
  • 10Seoud M, Nassar A, Usta I, et aL Gastrointestinal malformations in two infants born to women with hyperthyroidism untreated in the first trimester. Am J Perinatol, 2003,20:59-62.

共引文献42

同被引文献27

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部